Skip to main
IEX

IDEX (IEX) Stock Forecast & Price Target

IDEX (IEX) Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

IDEX is well-positioned for future growth with its strong financials, decentralized structure, and focus on high-growth industries. The company's strategic initiatives and improved organic sales outlook are expected to drive strong performance in the future. However, there are potential risks from external factors, and the company's neutral rating reflects these uncertainties.

Bears say

IDEX is a diversified industrial company that has historically been a high-quality industrial compounder, but over the past three years, the company's growth, profitability, and ROIC have been impacted by challenges in certain end markets (such as life sciences and semiconductors) and its pursuit of growthier acquisitions at higher multiples. While the company's pivot to targeted/integrated growth platforms has translated to strong orders in its health and science technologies segment and its balance sheet allows for ample capital optionality, there are still potential risks from tariffs, inventory resets, short-cycle businesses, and the impact of COVID-19. Overall, despite the company's strong fundamentals, the negative outlook is driven by concerns about its recent performance in key markets and potential risks in the future.

IDEX (IEX) has been analyzed by 8 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IDEX and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IDEX (IEX) Forecast

Analysts have given IDEX (IEX) a Buy based on their latest research and market trends.

According to 8 analysts, IDEX (IEX) has a Buy consensus rating as of May 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $233, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $233, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IDEX (IEX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.